Clincosm LogoSign in Get a demo

Small Cell Lung Cancer

Showing 51 - 75 of 284
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer Trial in Suzhou (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Suzhou University
Jul 19, 2022

Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib)

Not yet recruiting
  • Small Cell Lung Cancer
  • IBI-322 Plus Lenvatinib
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 14, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Small Cell Lung Cancer Trial in Australia, United States (APG-1252, Paclitaxel)

Terminated
  • Small Cell Lung Cancer
  • Plantation, Florida
  • +7 more
Jul 8, 2022

Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

Recruiting
  • Breast Cancer
  • +12 more
  • Checkpoint Blockade, Immune
  • Brussel, Anderlecht, Belgium
    Institut Jules Bordet
Jul 1, 2022

Small Cell Lung Cancer Trial in Hangzhou (1.Experimental: A (Part 1): Fluzoparib and SHR -1316, 2.Experimental: B (Part 1):

Completed
  • Small Cell Lung Cancer
  • 1.Experimental: A (Part 1): Fluzoparib and SHR -1316
  • +2 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Jun 16, 2022

Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Topotecan)

Terminated
Has Results
  • Small Cell Lung Cancer
  • Hot Springs, Arkansas
  • +49 more
May 12, 2022

Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)

Completed
Has Results
  • Small Cell Lung Cancer
  • +7 more
  • PDR001
  • LAG525
  • San Francisco, California
  • +19 more
May 4, 2022

Small Cell Lung Cancer Trial in Copenhagen (FLT-PET, MRI)

Completed
  • Small Cell Lung Cancer
  • FLT-PET
  • MRI
  • Copenhagen, Denmark
    Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshosp
May 3, 2022

NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Infusion of iNKT cells and CD8+T cells
  • Shanghai, Shanghai, China
    Shanghai Public Health Clinical Center
May 6, 2022

Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Carboplatin)

Terminated
Has Results
  • Small Cell Lung Cancer
  • Beverly Hills, California
  • +44 more
Apr 8, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Thoracic Tumors, NSCLC, Small Cell Lung Cancer Trial (ES101)

Withdrawn
  • Thoracic Tumors
  • +2 more
  • (no location specified)
Apr 22, 2022

Small Cell Lung Cancer Trial in Spain (BMS-986012, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Lung Cancer
  • Barcelona, Spain
  • +3 more
Apr 25, 2022

Small Cell Lung Cancer Trial in New Haven (Combination immunotherapy with Ipilimumab and Nivolumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • Combination immunotherapy with Ipilimumab and Nivolumab
  • New Haven, Connecticut
    Yale University, Yale Cancer Center
Apr 21, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

Recruiting
  • Metastatic Solid Tumor
  • +6 more
  • Surufatinib and Tislelizumab _ Part 1
  • Surufatinib and Tislelizumab _ Part 2
  • Tucson, Arizona
  • +17 more
Apr 1, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 8, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Brain Metastases, Small Cell Lung Cancer Trial in Birmingham (NovoTTF-200A, Stereotactic Radiosurgery (SRS))

Terminated
  • Brain Metastases
  • Small Cell Lung Cancer
  • NovoTTF-200A
  • Stereotactic Radiosurgery (SRS)
  • Birmingham, Alabama
    University of Alabama at Birmingham (UAB), Hazelrig-Salter Radia
Feb 17, 2022

Lung Cancer, Small Cell Lung Cancer, Durvalumab Trial in Guangzhou (Durvalumab, etoposide, and cisplatin/carboplatin followed by

Recruiting
  • Lung Cancer
  • +2 more
  • Durvalumab, etoposide, and cisplatin/carboplatin followed by durvalumab and olaparib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 17, 2022

Small Cell Lung Cancer, Extensive-stage Small Cell Lung Cancer Trial in United States (Guadecitabine, Carboplatin)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extensive-stage Small Cell Lung Cancer
  • Indianapolis, Indiana
  • +3 more
Feb 14, 2022

Small Cell Lung Cancer Trial in Boston (Olaparib, Temozolomide)

Active, not recruiting
  • Small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Jan 24, 2022